|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.840 USD | +3.20% |
|
-.--% | - |
| 24-11-20 | Exscientia plc(NasdaqGS:EXAI) dropped from S&P Global BMI Index | CI |
| 24-11-20 | Recursion Pharmaceuticals, Exscientia Complete Business Combination | MT |
| Market Cap | 500M 664M 583M 545M 936M 63.6B 959M 6.46B 2.53B 31.47B 2.49B 2.44B 109B | P/E 2022 |
-4.55x | P/E 2023 | -4.28x |
|---|---|---|---|---|---|
| Enterprise Value | 156M 207M 182M 170M 291M 19.81B 299M 2.01B 787M 9.8B 777M 760M 33.89B | EV / Sales 2022 |
1.9x | EV / Sales 2023 | 14.2x |
| Free-Float |
36.87% | Yield 2022 * |
-
| Yield 2023 | - |
| 1 day | +3.20% |
| 3 years | 3.8 |  | 9.12 |
| 5 years | 3.8 | | 30.38 |
| 10 years | 3.8 | | 30.38 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Tech/Sci/R&D Officer | 61 | 2024-06-05 | |
| Chief Tech/Sci/R&D Officer | - | 2022-04-30 | |
John Overington
CTO | Chief Tech/Sci/R&D Officer | - | 2024-04-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Mario Polywka
BRD | Director/Board Member | 63 | 2017-09-27 |
Robert Ghenchev
BRD | Director/Board Member | 43 | 2020-04-30 |
Elizabeth Crain
CHM | Chairman | 61 | 2024-02-11 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +3.20% | -.--% | -.--% | -37.47% | 633M | |
| +2.61% | +7.16% | -0.93% | +13.91% | 48.95B | |
| +1.90% | +24.70% | +27.25% | +9.47% | 40.75B | |
| -1.60% | -1.15% | +388.84% | +603.70% | 38.46B | |
| -0.98% | +2.28% | +7.02% | +45.34% | 36.38B | |
| +1.47% | +5.82% | +5.76% | +43.52% | 28.45B | |
| -0.94% | +0.05% | - | - | 16.62B | |
| +2.44% | +10.76% | +30.59% | +129.56% | 16.33B | |
| -1.14% | +6.52% | -3.80% | -29.33% | 13.65B | |
| +0.18% | -2.75% | +3.22% | +10.14% | 13.56B | |
| Average | +0.71% | +4.15% | +50.88% | +87.65% | 25.38B | |
| Weighted average by Cap. | +0.64% | +4.92% | +71.39% | +122.30% |
| 2022 | 2023 | |
|---|---|---|
| Net sales | 27.22M 36.17M 31.78M 29.66M 50.96M 3.46B 52.22M 352M 138M 1.71B 136M 133M 5.93B | 20.08M 26.67M 23.44M 21.88M 37.59M 2.56B 38.51M 259M 101M 1.26B 100M 97.98M 4.37B |
| Net income | -119M -158M -139M -129M -222M -15.11B -228M -1.53B -600M -7.48B -592M -579M -25.84B | -146M -194M -170M -159M -273M -18.57B -280M -1.89B -738M -9.19B -728M -712M -31.77B |
| Net Debt | -492M -654M -574M -536M -921M -62.6B -944M -6.36B -2.49B -30.97B -2.45B -2.4B -107B | -344M -457M -402M -375M -644M -43.79B -660M -4.45B -1.74B -21.67B -1.72B -1.68B -74.91B |
Employees
483
- Stock Market
- Stocks
- EXAI Stock
Select your edition
All financial news and data tailored to specific country editions
